Ofatumumab-containing medicines procurement 2026 – joint procurement

Summary

The tender concerns recurring deliveries of medicinal products containing the active substance ofatumumab that meet SUKL requirements. The contract covers ongoing supply to two hospitals, Fakultní nemocnice Olomouc and Fakultní nemocnice Hradec Králové, over a 48-month period, with an estimated total contract value of CZK 373,578,779. The procurement is conducted via an open procedure, with a tender submission deadline of 27 October 2026 at 10:00 local time. The award criterion is price; the contract will be awarded to the lowest-price bid; in case of equal prices, a draw will decide.